Trial Profile
Pharmacogenomic study Evaluating Relationship Between Efavirenz and CYP2B6 polymorphism in Patients with HIV-1-infection
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Pharmacogenomic
- 14 Dec 2015 New trial record